wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35623087-75514F57-D171-48AF-B910-662AA066D793
Q35623087-75514F57-D171-48AF-B910-662AA066D793
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35623087-75514F57-D171-48AF-B910-662AA066D793
High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer.
P2860
Q35623087-75514F57-D171-48AF-B910-662AA066D793
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35623087-75514F57-D171-48AF-B910-662AA066D793
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e9f6930c2c5f2d311f273f2873ea404080bd29ec
P2860
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.